Record Quarterly Revenues of $708.0 Million, a 26% Increase from a Year Ago Quarterly Adjusted EBITDA (non-GAAP) Increased 39 ...

Presented new subgroup analyses from phase 3 clinical trial of CAN-2409 in localized prostate cancer at the American Society ...

NEW YORK, NY / ACCESS Newswire / November 11, 2025 / There comes a point in every company’s journey when innovation stops being an idea and becomes infrastructure. SMX (NASDAQ:SMX) has reached that ...

Todd Sohn, an ETF strategist with Strategas, pointed to narrow credit spreads, historic ETF inflows and falling yields in ...

Technology executives and analysts expect artificial intelligence to generate hundreds of billions of dollars in value, yet ...

The blue-chip stock index has outpaced the S&P 500 and the Nasdaq over the past two full trading sessions as investors start to look beyond AI.